PURPOSE:The purpose of the current study is to assess the effect of titration of glipizide GITS at 4 month intervals on hemoglobin A1c levels. Previous fixed dose studies of glipizide GITS, a long-acting and daily dosed oral hypoglycemic agent for the treatment of type II diabetes, have demonstrated that no dose-response relationship exists between hemoglobin A1c and doses of GITS ranging from 5-60 mg. Conversely, a dose-response relationship was observed with fasting plasma glucose and doses ranging from 5-20mg. However, the duration of treatment at assigned doses was limited to 8 weeks. New data from the literature has indicated that decreases in hemoglobin A1c lag significantly behind decreases in fasting plasma glucose, and the appropriate time interval to observe stable hemoglobin A1c levels is 4 months. METHODS: This is a phase IV, open-label, multicenter study which will evaluate 75 patients (total # for all sites) in order to obtain 50 completed patients for evaluation. Patients in this study are started on glipizide GITS 5 mg daily for 4 months. At the end of the 4 month interval, if euglycemia is not achieved, the study medication is increased to the next dosage of 10 mg for 4 months, followed by 20 mg for the remaining 4 months if necessary. Patients are evaluated in a fasting state at the end of each 4 month interval. The tests performed include hemoglobin A1c, lipids, fructosamine, c-peptide, insulin and plasma glucose. Following a standardized breakfast of Sustacal, c-peptide, insulin, and plasma glucose levels are drawn at 30 minute intervals for 3 hours.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Telen, Marilyn J; Afenyi-Annan, Araba; Garrett, Melanie E et al. (2015) Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 55:1378-87
Barroso, Julie; Leserman, Jane; Harmon, James L et al. (2015) Fatigue in HIV-Infected People: A Three-Year Observational Study. J Pain Symptom Manage 50:69-79

Showing the most recent 10 out of 128 publications